Viewing Study NCT02068105


Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2026-01-01 @ 1:24 AM
Study NCT ID: NCT02068105
Status: COMPLETED
Last Update Posted: 2014-04-21
First Post: 2014-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ALKS 5461 in Healthy Volunteers
Sponsor: Alkermes, Inc.
Organization:

Study Overview

Official Title: A Phase 1, Randomized, Two-part Study to Evaluate the Relative Bioavailability of Two Formulations of ALKS 5461 and the Effect of Dose Titration of ALKS 5461 in Healthy Subjects
Status: COMPLETED
Status Verified Date: 2014-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a study to test the safety of ALKS 5461 in healthy adults.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: